volume 15 | number 11 | november 2009 nature medicine l e t t e r s Hyperinflammatory responses can lead to a variety of diseases, including sepsis 1 . We now report that extracellular histones released in response to inflammatory challenge contribute to endothelial dysfunction, organ failure and death during sepsis. They can be targeted pharmacologically by antibody to histone or by activated protein C (APC). Antibody to histone reduced the mortality of mice in lipopolysaccharide (LPS), tumor necrosis factor (TNF) or cecal ligation and puncture models of sepsis. Extracellular histones are cytotoxic toward endothelium in vitro and are lethal in mice. In vivo, histone administration resulted in neutrophil margination, vacuolated endothelium, intra-alveolar hemorrhage and macro-and microvascular thrombosis. We detected histone in the circulation of baboons challenged with Escherichia coli, and the increase in histone levels was accompanied by the onset of renal dysfunction. APC cleaves histones and reduces their cytotoxicity. Co-infusion of APC with E. coli in baboons or histones in mice prevented lethality. Blockade of protein C activation exacerbated sublethal LPS challenge into lethality, which was reversed by treatment with antibody to histone. We conclude that extracellular histones are potential molecular targets for therapeutics for sepsis and other inflammatory diseases.
Macrophage activation leads to production of several mediators, including TNF and high-mobility group box-1 protein (HMGB1), that contribute to the severity of sepsis 1 . Recombinant human APC is approved by the US Food and Drug Administration for the treatment of severe sepsis, probably owing to its anti-inflammatory and cytoprotective functions rather than its anticoagulant activity [2] [3] [4] [5] [6] . To explore other physiological mediators involved in the pathogenesis of sepsis, we cultured LPS and interferon-γ-activated mouse macrophage RAW264.7 cells in the presence or absence of recombinant human APC under the hypothesis that APC might proteolytically degrade a key mediator. We then compared the cytotoxicity toward endothelium between the two conditioned media. The medium from LPS and interferon-γ-activated macrophages was toxic to the human endothelial cell line EA.hy926, as measured by propidium iodide staining. APC reduced this cytotoxicity ( Supplementary  Fig. 1a ). Comparing these media by SDS-PAGE, we observed three new bands of 10 kDa, 13 kDa and 15 kDa in the presence of APC ( Supplementary Fig. 1b) . Sequencing identified the 10-kDa protein as the mouse histone H4 (H4) internal sequence methyl-Lys20-Ile34. The 13-kDa protein matches the mouse histone H3 (H3) internal sequence Lys27-Lys36. The N-terminal sequence of the 15-kDa band protein could not be determined by direct Edman sequencing. After in-gel tryptic digestion, tandem mass spectrometry identified three peptide sequences that match the mouse histone H2A protein sequences Ala21-Arg29, His82-Arg88 and Val100-Lys118. These data suggested that extracellular histones are cytotoxic toward endothelium and that APC is cytoprotective because it cleaves them. We confirmed the H3 identification by western blotting with antibody to H3 (Supplementary Fig. 1c ). The apparent increase in histone fragments in the conditioned medium of activated macrophages cultured with APC might indicate that APC can cleave not only the soluble extracellular histones in the medium but also the histones associated with the activated cells or DNA.
To determine whether histones are toxic to endothelium and whether APC can lower the histone cytotoxicity, we treated EA.hy926 cells with a mixture of histones or five individual histones. We found that a mixture of histones was cytotoxic to these cells, and this toxicity was mainly due to histones H3 and H4 ( Fig. 1a) . Inclusion of APC lowered this cytotoxicity ( Fig. 1b) . Histones have similar or greater cytotoxicity toward primary human endothelial cells (HUVECs), and APC also reduced this cytotoxicity ( Supplementary Fig. 2 ). When incubated with endothelium, H4 elicited calcium fluxes, which were blocked by an antibody to H4 (Supplementary Fig. 3) .
To test whether APC could cleave histones in a purified system, we incubated the purified H3 or H4 with APC. APC cleaved these histones in a dose-dependent fashion ( Fig. 1c) . Liposomes containing phosphatidylethanolamine enhanced histone cleavage by APC ( Fig. 1d) , similar to the effect of phosphatidylethanolamine on APC inactivation of coagulation factor Va 7 . This lipid mixture is presumably a mimic of a cell surface membrane after injury or exposure to a potent agonist.
Histone cytotoxicity is concentration dependent in vitro ( Fig. 2a ). Adding 10 nM and 100 nM APC to histones reduced the cytotoxicity at low histone concentration (25 µg ml -1 ) but only 100 nM APC effectively reduced the cytotoxicity of histones at 50 µg ml -1 ( Fig. 2a) . Preincubation of histones (50 µg ml -1 ) and APC (100 nM) l e t t e r s together for 5 min lowered cytotoxicity ( Fig. 2b) . This cytoprotective effect of APC against histones is mediated by cleavage of histones ( Fig. 2c) and not by APC-mediated protease-activated receptor-1 (PAR1) signaling, a known alternative cytoprotective function of APC 8 , as APC was inactivated by d-phenylalanyl-l-prolyl-l-arginine chloromethyl ketone (PPACK) after preincubation with the histones to prevent the APC-mediated activation of PAR1. Protein C is converted to APC by the thrombomodulin-thrombin complex on endothelium. Endothelial cells were not protected from histone cytotoxicity with either protein C or thrombin but were protected when both protein C and thrombin were present ( Fig. 2d) , in which conditions about 6% of protein C was converted to APC (data not shown). Fully activated protein C provided the best protection ( Fig. 2d) .
To test whether extracellular histones may be involved in the pathogenesis of diseases and whether APC can cleave these histones in vivo, we examined frozen archival plasma samples from a nonhuman primate model of sepsis in which baboons were challenged with a lethal dose of E. coli 9 . Infusion of APC rescued these baboons 9 . We measured extracellular histones in the plasma from baboons challenged with the lethal dose of E. coli either in the absence or presence of infused APC. We detected intact H3 in the plasma of two challenged baboons by western blotting, and the H3 concentration reached ~15 µg ml -1 8 h after challenge ( Fig. 2e) . We were unable to measure other histone concentrations by this method because those antibodies were not sensitive enough. The increase in H3 concentration accompanied the onset of acute renal failure, as indicated by a high serum creatinine at the times indicated (c) in EA.hy926 cells for 1 h with calf thymus histones (50 µg ml -1 ) incubated with APC (100 nM) at 37 °C for the indicated time and l e t t e r s concentration, 2.65 ± 0.05 mg dl -1 (normal range: 0.7-1.4 mg dl -1 ) 8 h after challenge. We observed both intact and cleaved H3 in the plasma of two baboons challenged with a lethal dose of E. coli and given APC, indicating that APC can cleave extracellular histones in vivo ( Fig. 2e) . APC co-infusion protected renal function, as indicated by the normal serum creatinine level, 1.15 ± 0.15 mg dl -1 at 8 h after challenge. We also found high levels of extracellular histones in frozen archival plasma samples from some human individuals with sepsis ( Fig. 2f and data not shown), consistent with the presence of nucleosomes 10 . In at least one human subject treated with APC, we observed considerable cleavage of H3 (Fig. 2f) . Thus, APC cleavage of extracellular histones in the circulation seems to be a previously unknown mechanism contributing to its beneficial effects in sepsis.
To test the toxic effect of histones in vivo, we injected 75 mg histones per kg intravenously into mice. All mice (n = 5) died within 1 h of injection ( Fig. 3a) . Co-injection of recombinant APC (5 mg per kg body weight) rescued all of the mice (n = 5) challenged with the same lethal dose of histones (Fig. 3a) . The ratio of APC to H3 that we used to rescue the mice in vivo is similar to the one we used in the endothelial cytoprotection experiments. Mice challenged with a sublethal dose of histones (50 mg per kg body weight) showed many of the following characteristics of septic mice. l e t t e r s showed neutrophil margination and accumulation in the alveolar microvessels ( Fig. 3b-d) , vacuolated endothelial and pulmonary epithelial cells (Fig. 3e-f) , intra-alveolar hemorrhage ( Supplementary  Fig. 4a,b) and platelet-and fibrin-rich microthrombi ( Supplementary  Fig. 4c,d,f,g) , intra-alveolar fibrin deposition (Supplementary Fig. 4e ) and fibrin and collagen accumulation within the interalveolar septum (Supplementary Fig. 4f-g) .
To test the pathological importance of extracellular histones in the progression of the septic response, we infused antibody to H4 together with a high dose of LPS (Fig. 4a) . The antibody protected the mice, indicating that H4 is a major mediator of injury in sepsis. To test whether inhibition of histone cytotoxicity by endogenous APC does indeed have a major role in protection from death in a model of sepsis, we challenged mice with a low dose of LPS in the absence or presence of an antibody to protein C. This antibody, which blocks protein C activation both in vitro and in vivo 11 , converted a nonlethal LPS dose into a lethal LPS dose (Fig. 4b) . This result is consistent with the recent finding that acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency 12 and clinical observations that acquired severe protein C deficiency is associated with early death in individuals with sepsis 13 . Infusion of H4 antibody together with LPS rescued the mice from the lethality caused by LPS and the blockade of protein C activation (Fig. 4b) .
In contrast, the antibody to histone H2B failed to rescue the mice (Fig. 4b) . We detected H3 in plasma from mice challenged with a lethal dose of LPS, and the concentration of H3 was lowered by treatment with H4-specific antibody (Fig. 4c) , indicating a role for H4 in facilitating histone release. When we injected a sublethal dose of LPS plus an antibody to protein C into mice, the levels of H3 were higher than in mice injected with LPS alone (Fig. 4d) , suggesting a role of APC in regulating extracellular histone levels in vivo.
Cecal ligation and puncture (CLP) is often considered a good animal model of sepsis. Antibody to H4 also lowered the mortality of mice in the CLP model ( Fig. 4e) . We found that delay of treatment and the use of antibiotics were necessary to achieve a therapeutic benefit with the antibody treatment, perhaps because of the functions of histones in innate immunity [14] [15] [16] .
TNF can also be used to elicit a hyperinflammatory state mimicking many aspects of sepsis 17 . Antibody to H4 reduced mortality in mice subjected to TNF injection (Fig. 4f) .
Extracellular histones, mainly H3 and H4, seem to be both biomarkers of disease progression and therapeutic targets in sepsis and other inflammatory diseases. An effective histone blocking agent, such as the antibody described here, might prove therapeutic without the bleeding complications that can result from APC therapy. If effective, this approach is especially attractive in patients after surgery or patients with sepsis following trauma who are currently excluded from APC therapeutic intervention.
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